JONI SCHROEDER: Open Payments
NPI 1780652313 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 16 payments from 9 companies in 2025. Trend: 2023 $104 · 2024 $315 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| ABBVIE INC. | 1 | $29 |
| Pylant Medical | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $15 |
| Pulmonx Corporation | 1 | $15 |
Products named: DATROWAY, KEYTRUDA, IMFINZI, EMRELIS, Enhertu, LIBTAYO, Tecentriq, CHARTIS CATHETER.
Industry payments across OK — which companies pay providers there.
